Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Belina, N. Shaporova, M. Menshutina, V. Achkasova, O. Galkina, M. Kadinskaya, V. Didur (Saint-Petersburg, Russian Federation). The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH. Eur Respir J 2011; 38: Suppl. 55, 4211

Member's Comments

No comment yet.

Related content which might interest you: Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 1 year evolution of COPD patients systemic endothelial dysfunction Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005 Endothelial dysfunction, smoking and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013 Evaluation of mechanisms determining endothelial function in patients with COPD Source: Annual Congress 2012 - Lung, heart, muscles and brain: the pathway of oxygen during exercise in health and COPD Year: 2012 The role of endothelial dysfunction in smoker and ex-smoker patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 A potential role for sildenafil in the management of pulmonary hypertension associated with parenchymal lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 608s Year: 2004 Smoking induced pulmonary vascular remodelling in patients with mild COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Gender differences in formation of endothelial dysfunction (ED) extension in COPD patients Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Role of diaphragm dysfunction and nutritional status on dyspnea pathogenesis in patients with COPD. Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Hypoxemia as a risk factor for endothelial dysfunction in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 New markers of endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007